TMCnet News
Research and Markets: Global Ulcerative Colitis Therapeutics Pipeline Review 2014 - Analysis of 68 Companies & 113 Drug ProfilesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/p2n6ld/ulcerative) has announced the addition of the "Ulcerative Colitis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ulcerative Colitis and special features on late-stage and discontinued projets. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope
For more information visit http://www.researchandmarkets.com/research/p2n6ld/ulcerative
|